View Author
scopus: 8387401900

Dekker, A.T. den

( A.T. den Dekker)


cancer breast patient ncor 2 cell lines breast cancer expression tamoxifen resistance level tamoxifen resistance tamoxifen-resistant cell lines agthoven therapy group tumours study gene expression patterns table 2 mrna levels figure van agthoven integration treatment analysis mrna levels netherland 0.001 sieuwert meijer-van gelder gene expression klijn jg dorsser protein breast cancer patients tumour breast cancer res factor model profile tamoxifen-resistant british journal foeken receptor tumour aggressiveness research prognostic adjuvant difference disease gene expression profile tamoxifen therapy anti-oestrogen outcome target breast cancer cells pattern result 2009 b foekens ja van agthoven t british p-value journal benefit association survival month center rotterdam tamoxifen treatment portengen h cell model insertion mutagenesis esr 1 rotterdam era-positive breast cancer oestrogen aggressiveness zr -75-1 cells rt – pcr




1 Most Recent Publications

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer (Article)
Agthoven, T.L.A. van Sieuwerts, A.M. Foekens, J.A. Dorssers, L.C.J. Veldscholte, J. Meijer van Gelder, M.E. Smid, M. Brinkman, A. Dekker, A.T. den Leroy, I.M. IJcken, W.F.J. van Sleijfer, S.
2009-12-01